Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care

PURPOSE: The investigation of multiple molecular targets with next-generation sequencing (NGS) has entered clinical practice in oncology, yielding to a paradigm shift from the histology-centric approach to the mutational model for personalized treatment. Accordingly, most of the drugs recently appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vingiani, Andrea, Agnelli, Luca, Duca, Matteo, Lorenzini, Daniele, Damian, Silvia, Proto, Claudia, Niger, Monica, Nichetti, Federico, Tamborini, Elena, Perrone, Federica, Piccolo, Alberta, Manoukian, Siranoush, Azzollini, Jacopo, Brambilla, Marta, Colombo, Elena, Lopez, Salvatore, Vernieri, Claudio, Marra, Francesca, Conca, Elena, Busico, Adele, Capone, Iolanda, Bozzi, Fabio, Angelini, Marta, Devecchi, Andrea, Salvatori, Rebecca, De Micheli, Valentina, Baggi, Anna, Pasini, Silvia, Jommi, Claudio, Ladisa, Vito, Apolone, Giovanni, De Braud, Filippo, Pruneri, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581623/
https://www.ncbi.nlm.nih.gov/pubmed/37487147
http://dx.doi.org/10.1200/PO.23.00067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581623/
https://www.ncbi.nlm.nih.gov/pubmed/37487147
http://dx.doi.org/10.1200/PO.23.00067

Ejemplares similares